Can Medistim (OB:MEDI) Q3 Earnings Sustain Its Premium Stock Price?
Medistim walked into its Q3 2026 earnings already on a tear, with the share price at NOK 300 after a strong run over the past quarter. The fresh numbers did not just keep pace with that optimism. They raised the bar. Revenue reached NOK 210 million and operating margin landed around 30%, pointing to a business that is scaling cleanly rather than only focusing on growth for its own sake. The key development is sentiment. Traders have been paying up for Medistim on a premium P/E, yet the latest...
Medistim walked into its Q3 2026 earnings already on a tear, with the share price at NOK 300 after a strong run over the past quarter. The fresh numbers did not just keep pace with that optimism. They raised the bar. Revenue reached NOK 210 million and operating margin landed around 30%, pointing to a business that is scaling cleanly rather than only focusing on growth for its own sake. The key development is sentiment. Traders have been paying up for Medistim on a premium P/E, yet the latest...
What's Your Reaction?
